News & Events

Inga Patarčić, who holds a PhD in bioinformatics and molecular biology, is a research data manager at the Max Delbrück Center. A native of Croatia, she recommends a book about Buddhism and philosophy, but also about egoism in research and open science.

The Berlin biotech Glycotope and the Max Delbrück Center have signed an agreement to explore the potential of combining Glycotope’s tumor-specific antibodies with CAR technology developed by the Max Delbrück Center. Their common goal: advancing immunotherapies against solid tumors.

People with hypertension are at the greatest risk of developing serious cardiovascular diseases. A team of researchers at the Experimental and Clinical Research Center are now investigating whether probiotics in food supplements can support drug therapies or even delay the need to start them.

People with Huntington’s disease lose control of their bodies and minds. The symptoms are caused by protein clumps in the nerve cells. Supported by a Marie Skłodowska-Curie Individual Fellowship, Andrea Quezada aims to create atomic models of these fibrils at the Max Delbrück Center.

After spending many years researching together, a group of scientists has founded CARTemis Therapeutics, a spin-off from the Max Delbrück Center. Uta Höpken, Armin Rehm, Anthea Wirges, and Mario Bunse want to use novel CAR T-cell therapies to help patients with cancers that are currently untreatable.

Cryo-electron microscopy allows structural biologists to look at the most minute building blocks of life. We celebrated the opening of the joint Core Facility and the corresponding research building of Charité – Universitätsmedizin Berlin and the Max Delbrück Center with a symposium.

Dr. Isolde Dietrich was instrumental in developing cryo-electron microscopy. But who was she? One thing is certain: physics was her passion. And she wanted to make it easier for younger female colleagues to enter science. The Max Delbrück Center is now dedicating a research building in her name.

Young students are fascinated by the experiments they can participate in at the Gläsernes Labor (Life Science Learning Lab). Thanks to a special fundraiser, socially disadvantaged children from the district of Marzahn-Mitte were able to don lab coats and carry out some thrilling research.

The UNIPRENEURS Initiative has recognized the entrepreneurial spirit of 20 professors, among them ECRC researcher Simone Spuler. As a co-founder of the startup MyoPax, she is pioneering stem cell technology to develop regenerative therapies for previously incurable muscle diseases.